University of Southern California, Kenneth Norris Cancer Center — Los Angeles, California

University of Southern California, Kenneth Norris Cancer Center is a clinical research site located in Los Angeles, California, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Southern California, Kenneth Norris Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Acute Myelogenous Leukemia.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Southern California, Kenneth Norris Cancer Center?

University of Southern California, Kenneth Norris Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Southern California, Kenneth Norris Cancer Center conducted?

University of Southern California, Kenneth Norris Cancer Center has 1 clinical trials on record. Their work covers Acute Myelogenous Leukemia.

Is University of Southern California, Kenneth Norris Cancer Center accredited by Crixeo Health?

University of Southern California, Kenneth Norris Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Southern California, Kenneth Norris Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.